ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
twitter youtube facebook linkedin instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • Featured Industry Events
  • ATTENDEE MAP & PHOTOS
  • About Us
  • Register Now
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • Featured Industry Events
  • ATTENDEE MAP & PHOTOS
  • About Us
  • Register Now
loading...

Home

Loading Events

View Featured Industry Events

  • This event has passed.

Applying Multidisciplinary Expertise and Heterogeneous Skills in Clinical Practice: Transforming Non-small Cell Lung Cancer Treatment with Immunotherapy

September 11 @ 19:00 - 20:00 SMT

  • « Tailoring Treatment in Metastatic NSCLC: Advances in Targeted Therapy and Post-progression Treatment Options
  • Taking Aim With the Next Wave of Antibody–Drug Conjugates in NSCLC: Rational Strategies for Addressing the Unmet Needs of Diverse Patient Populations With TROP2- and HER3-Targeting Therapies and Other ADC-Based Regimens »
+ Add to iCalendar + Add to Google Calendar

Details

Date:
September 11
Time:
19:00 - 20:00 SMT
Event Category:
Satellite CME Symposium
  • « Tailoring Treatment in Metastatic NSCLC: Advances in Targeted Therapy and Post-progression Treatment Options
  • Taking Aim With the Next Wave of Antibody–Drug Conjugates in NSCLC: Rational Strategies for Addressing the Unmet Needs of Diverse Patient Populations With TROP2- and HER3-Targeting Therapies and Other ADC-Based Regimens »

IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2023 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy